SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Clinical trial NCT06205316 · RECRUITING

Trial details

NCT number: NCT06205316
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biochemically Recurrent Prostate Carcinoma Oligometastatic Prostate Carcinoma Recurrent Prostate Adenocarcinoma Stage IIB Prostate Cancer AJCC v8 Stage IIC Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8

Start date: 2024-01-22
Primary completion: 2030-01-22
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.